Pharma & Biotech
Eli Lilly Commits Billions to Boost Production Amid Soaring Demand
To address overwhelming global demand for its blockbuster diabetes and weight-loss treatments, Eli Lilly and Company is embarking on another...
InMed Pharmaceuticals: The Critical Search for Clinical Validation
For emerging biotechnology firms such as InMed Pharmaceuticals, the current investment climate presents a dual challenge. Sustaining costly research operations...
Gerresheimer Faces Escalating Legal and Regulatory Scrutiny
The financial reporting crisis at packaging specialist Gerresheimer has entered a new phase, with legal action now a distinct possibility....
Institutional Investors Double Down on BioNTech’s Strategic Pivot
A significant strategic transition is underway at Mainz-based biotechnology firm BioNTech. While news of the impending departure of its two...
ImmunityBio Receives Significant Endorsement in Updated Cancer Treatment Guidelines
A key medical authority has broadened its treatment recommendations for bladder cancer, providing a notable boost for ImmunityBio's commercial prospects....
Ocugen Shares Surge to Annual Peak Following Bullish Analyst Initiation
A new research report from Canaccord Genuity triggered a significant rally for Ocugen Inc. on Tuesday. The firm initiated coverage...
Analyst Sentiment Shifts as Hims & Hers Forges New Path with Pharma Giant
A significant strategic pivot by telehealth provider Hims & Hers has prompted a swift reassessment from Wall Street. The company...
Anavex Shares Show Signs of Neuroregenerative Promise in Parkinson’s Research
New preclinical findings for Anavex Life Sciences' lead drug candidate, Blarcamesine, were unveiled at the AD/PD 2026 conference in Copenhagen....
Shifting Focus: How Neutra is Pivoting to Clinical Trial Management
The strategic direction for Neutra has undergone a significant change, with its core emphasis now placed squarely on the clinical...
Krystal Biotech’s Global Ambitions: From Vyjuvek Launch to Pipeline Catalysts
Having secured U.S. approval for its gene therapy Vyjuvek, Krystal Biotech is now executing a deliberate strategy to capture international...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
